Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Personalized Medicine|December 1, 2025
How to treat BRAF mutant metastatic melanoma?Maria Cristina Sini, Milena Casula, Marina Pisano, et al.Current Oncology Reports|September 16, 2018
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing ApproachesGiuseppe Palmieri, Maria Colombino, Milena Casula, et al.Journal of Proteome Research|August 6, 2011
Proteomic profiling of human melanoma metastatic cell line secretomesMicaela Rocco, Livia Malorni, Rosaria Cozzolino, et al.Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Genetic Instability Markers in CancerGiuseppe Palmieri, Milena Casula, Antonella Manca, et al.Frontiers in Oncology|September 1, 2015
Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic TargetsGiuseppe Palmieri, MariaNeve Ombra, Maria Colombino, et al.Critical Reviews in Oncology/Hematology|March 6, 2017
Long non-coding RNA CASC2 in human cancerGiuseppe Palmieri, Panagiotis Paliogiannis, Maria Cristina Sini, et al.Critical Reviews in Oncology/Hematology|July 8, 2024
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyondMaria Colombino, Milena Casula, Panagiotis Paliogiannis, et al.Experimental Hematology & Oncology|February 7, 2026
Mutation rates in main tumour driver genes predict prognosis in patients with superficial spreading or nodular primary melanoma: results from the CARAMEL study by the Italian Melanoma Intergroup (IMI)Maria Cristina Sini, Jerry Polesel, Sara Simi, et al.Cancer|July 13, 2002
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinomaPaola Baldinu, Antonio Cossu, Antonella Manca, et al.Melanoma Management|September 8, 2018
Epidemiological and genetic factors underlying melanoma development in ItalyGiuseppe Palmieri, Maria Colombino, Milena Casula, et al.Pageof 5